Skip to content

Clinical trials

Phase 3 Carcinoma, Non-Small-Cell Lung trials in Finland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 3 Country / region: Finland Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20072
20082
20101
20111
20143
20151
20181
20191
20221
20231
20243
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting4
Terminated4
Recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb3
GlaxoSmithKline3
Pfizer3
AbbVie2
Eli Lilly and Company2
Merck Sharp & Dohme LLC2
Novartis Pharmaceuticals2
Bayer1
Boehringer Ingelheim1
Celgene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung21
Neoplasm Metastasis3
Lung Neoplasms2
Carcinoma, Adenosquamous1
Carcinoma, Large Cell1
Carcinoma, Squamous Cell1
Neoplasms1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.